Your browser doesn't support javascript.
loading
Circ_0072088 promotes breast carcinoma progression via modulating miR-607/RNF2 axis.
Chen, Mingxi; Hui, Yang; Tian, Bo.
Afiliação
  • Chen M; Department of Surgery, Xi'an Hospital of Traditional Chinese Medicine Xi'an 710021, Shaanxi, China.
  • Hui Y; Department of Surgical Oncology, Affiliated Hospital of Shaanxi University of Chinese Medicine Xianyang 712000, Shaanxi, China.
  • Tian B; Department of Surgery, Hospital of Northwestern Polytechnical University Xi'an 710072, Shaanxi, China.
Am J Transl Res ; 16(4): 1401-1414, 2024.
Article em En | MEDLINE | ID: mdl-38715837
ABSTRACT

OBJECTIVES:

To explore how the circular non-coding RNA circ_0072088 influences the progression of breast carcinoma (BC) by affecting cell behavior.

METHODS:

We measured the levels of circ_0072088, microRNA-607 (miR-607), and ring finger protein 2 (RNF2) mRNA levels in BC tissues and cell lines using quantitative real-time PCR. We also conducted cell counting kit-8 (CCK-8), BrdU incorporation, and flow cytometry assays to assess cell viability, cell cycle, and apoptosis, respectively.

RESULTS:

We observed increased levels of circ_0072088 and RNF2, and decreased levels of miR-607 in BC tissues. Overexpressing circ_0072088 promoted BC cell proliferation and cell cycle progression while inhibiting apoptosis. Conversely, silencing circ_0072088 had the opposite effects. Our data suggest that circ_0072088 directly targets and downregulates miR-607, which in turn upregulates RNF2, a target of miR-607. Moreover, miR-607 overexpression could mitigate the pro-proliferative and anti-apoptotic effects of circ_0072088 on BC cells.

CONCLUSION:

Circ_0072088 drives BC progression by downregulating miR-607 and upregulating RNF2, thereby promoting cell proliferation and cycle progression while reducing apoptosis.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article